Safety of ipilimumab in patients (pts) with untreated, advanced melanoma alive beyond 2 years: Results from a phase III study Meeting Abstract


Authors: Thomas, L.; Wolchok, J.; Garbe, C.; Lebbé, C.; Bondarenko, I.; Rodrigues, K.; Konto, C.; Chin, K.; Francis, S.; Robert, C.
Abstract Title: Safety of ipilimumab in patients (pts) with untreated, advanced melanoma alive beyond 2 years: Results from a phase III study
Meeting Title: IPOS 14th World Congress and the COSA 39th Annual Scientific Meeting
Journal Title: Asia-Pacific Journal of Clinical Oncology
Volume: 8
Issue: Suppl. 3
Meeting Dates: 2012 Nov 13-15
Meeting Location: Brisbane, Australia
ISSN: 1743-7555
Publisher: Wiley Blackwell  
Date Published: 2012-11-01
Start Page: 309
Language: English
ACCESSION: WOS:000310544400280
PROVIDER: wos
PUBMED: 23115798
DOI: 10.1111/ajco.12029
Notes: --- - Meeting Abstract: 729 - "3" - SI - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok